Canara Robeco Emerging Equities Fund (G) buys Ipca Laboratories, Dabur India

by admin on March 9, 2009

Canara Robeco Emerging Equities Fund (G) took fresh exposure to two stocks in February 2009. The scheme has purchased 3470 units (2.06%) of Ipca Laboratorie and 12410 units (2.03%) of Dabur India.

The scheme did not exit completely from any stocks in February 2009.

Sector-wise, the scheme took fresh exposure to Pharmaceuticals – Indian – Bulk Drugs & Formulation at 2.06% and Personal Care ? Indian at 2.03% in February 2009.Sector-wise, the scheme did not exit completely from any sector in February 2009.

The scheme had highest exposure to PVR with 37500 units (5.31% of portfolio size) followed by Colgate-Palmolive (India) with 6000 units (5.00%), Federal Bank with 20000 units (4.46%) and Gujarat State Petronet with 65000 units (3.82%) among others in February 2009.

It has reduced its exposure in Allied Digital Services to 10000 units (by 1.59%), Pantaloon Retail (India) to 9900 units (by 0.47%), Bilcare to 4500 units (by 0.44%) and ABG Infralogistics to 11587 units (by 0.41%) among others in February 2009.

Sector-wise, the scheme had highest exposure to Entertainment / Electronic Media Software at 9.13% (9.67% in January 2009), followed by Computers – Software – Medium / Small at 7.27% (8.99%), Engineering – Turnkey Services at 5.74% (6.26%) and Personal Care ? Multinational at 5.00% (2.11%) among others in February 2009.

Sector wise, the scheme had reduced exposure to Computers – Software – Medium / Small to 7.27% (by 1.72%), Entertainment / Electronic Media Software to 9.13% (0.54%), Engineering – Turnkey Services to 5.74% (0.52%) and Textiles ? Products to 2.16% (0.47%) among others in February 2009.

Related posts:

  1. Buy Ipca Laboratories, target of Rs 500: Karvy
  2. Dabur India has posted a net profit of Rs 1130.70 million
  3. HDFC Arbitrage Fund Discontinues Monthly Dividend Option
  4. Maruti Suzuki Dec sales
  5. Steps For Investing in Equities

Leave a Comment

Previous post:

Next post: